bognortyres.com – Daily Headlines & Expert Reports

Neuralink is set to begin a groundbreaking clinical trial in October 2025, offering hope to individuals with severe speech impairments. The FDA-cleared study will test Neuralink's brain implant, designed to translate thoughts directly into text. This technology could revolutionize communication for those affected by conditions like spinal injuries and ALS.